Dade completes sale of Bartels:
This article was originally published in Clinica
Executive Summary
Dade International has completed the sale of its Bartels subsidiary to Intracel, a supplier of genetically engineered viral proteins and antibodies. Bartels has been up for sale since Dade decided earlier this year that the viral test and reagent business was outside its core activities (see Clinica No 661, p 13). Based in Cambridge, Massachusetts, Intracel has 45 employees. Terms of the transaction were not disclosed.